{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001130156.2:c.137A>G",
          "cDNA Change": {
            "transcript": "NM_001130156.2",
            "ref": "A",
            "alt": "G",
            "position": "137"
          },
          "Protein Change": {
            "ref": "Glu",
            "alt": "Lys",
            "position": "46"
          },
          "Description in input context": "E46K mutation in α-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005321"
  },
  "Experiment Method": [
    {
      "Assay Method": "Planar lipid bilayer analysis",
      "Material used": {
        "Material Source": "In vitro",
        "Material Name": "Phosphatidylcholine bilayers",
        "Description": "Ion channel formation was analyzed using phosphatidylcholine bilayers."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130156.2:c.137A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered ion channel conductivity and selectivity",
          "Result Description": "E46K mutation reduced channel conductivity by 40% and increased selectivity for K+ over Na+ compared to wild-type. GM3 gangliosides restored normal conductivity, while GM1 had no effect."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control for ion channel formation."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No α-synuclein was used as a negative control for ion channel formation."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to compare channel conductance between wild-type and E46K mutant."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Channel conductivity within ±15% of wild-type values.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Channel conductivity deviating by >25% from wild-type values.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "N.D."
      }
    },
    {
      "Assay Method": "Langmuir monolayer analysis",
      "Material used": {
        "Material Source": "In vitro",
        "Material Name": "Langmuir monolayers",
        "Description": "Monolayer stability and α-synuclein interactions were analyzed using Langmuir monolayers."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130156.2:c.137A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced monolayer stability and altered surface interactions",
          "Result Description": "E46K mutation decreased monolayer stability by 30% compared to wild-type. GM3 gangliosides enhanced stability, while GM1 had no effect."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control for monolayer stability."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No α-synuclein was used as a negative control for monolayer stability."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to compare monolayer stability between wild-type and E46K mutant."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Monolayer stability within ±15% of wild-type values.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Monolayer stability deviating by >25% from wild-type values.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "N.D."
      }
    }
  ]
}